AstraZeneca warns UK on innovation

Jun 2, 2015 : A decision by the UK’s National Health Service not to stock a new cancer drug being sold by AstraZeneca has seen the British pharmaceuticals company accuse the country of stymieing scientific innovation. The FT's Andrew Ward explains the predicament.
1 - 12 EDITOR'S CHOICE (78)